Scientists use CRISPR gene editing to reverse chemo resistance in lung cancer – NaturalNews.com
Researchers at ChristianaCare’s Gene Editing Institute successfully used CRISPR-Cas9 to disable the NRF2 gene, reversing chemotherapy resistance in lung cancer. This approach could also apply to liver, esophageal and head/neck…